Full Name
Wei Peng Yong
Variants
Yong, W.-P.
Yong, W.P.
Peng, Y.W.
 
 
 
Email
csiywp@nus.edu.sg
 

Publications

Results 21-40 of 74 (Search time: 0.02 seconds).

Issue DateTitleAuthor(s)
2120-Feb-2021Combined inhibition of PD-1/PD-L1, Lag-3, and Tim-3 axes augments antitumor immunity in gastric cancer–T cell coculture modelsMimura, Kosaku; Kua, Ley-Fang ; Xiao, Jin-Fen ; Asuncion, Bernadette Reyna; Nakayama, Yuko; Syn, Nicholas; Fazreen, Zul; Soong, Richie ; Kono, Koji; Yong, Wei-Peng 
222017Combined use of irinotecan with histone deacetylase inhibitor belinostat could cause severe toxicity by inhibiting SN-38 glucuronidation via UGT1A1Wang, L ; Chan, C.E.L; Wong, A.L.-A ; Wong, F.C; Lim, S.W ; Chinnathambi, A; Alharbi, S.A; Lee, L.S.-U ; Soo, R ; Yong, W.P ; Lee, S.C ; Ho, P.C.-L ; Sethi, G ; Goh, B.C 
2321-May-2010Comprehensive profiling of DNA methylation in colorectal cancer reveals subgroups with distinct clinicopathological and molecular featuresAng, P.W.; Loh, M. ; Liem, N.; Lim, P.L.; Grieu, F.; Vaithilingam, A.; Platell, C.; Yong, W.P. ; Iacopetta, B.; Soong, R. 
2413-Mar-2014Diagnostic and prognostic utility of a DNA hypermethylated gene signature in prostate cancerGoh, L.K.; Liem, N.; Vijayaraghavan, A.; Chen, G.; Lim, P.L.; Tay, K.-J.; Chang, M.; Low, J.S.W.; Joshi, A.; Huang, H.H.; Kalaw, E.; Tan, P.H.; Hsieh, W.-S.; Yong, W.P. ; Alumkal, J.; Sim, H.G.
252018Discovering novel SNPs that are correlated with patient outcome in a Singaporean cancer patient cohort treated with gemcitabine-based chemotherapyLimviphuvadh, V; Tan, C.S; Konishi, F; Jenjaroenpun, P; Xiang, J.S; Kremenska, Y; Mu, Y.S; Syn, N; Lee, S.C; Soo, R.A ; Eisenhaber, F ; Maurer-Stroh, S ; Yong, W.P 
261-Dec-2021Disruption of her2-induced pd-l1 inhibits tumor cell immune evasion in patient-derived gastric cancer organoidsChakrabarti, J; Koh, V ; Steele, N; Hawkins, J; Ito, Y ; Merchant, JL; Wang, J; Helmrath, MA; Ahmad, SA; So, JBY ; Yong, WP ; Zavros, Y
2728-Mar-2014DNA methylation subgroups and the CpG island methylator phenotype in gastric cancer: A comprehensive profiling approachLoh, M.; Liem, N.; Vaithilingam, A.; Lim, P.L.; Sapari, N.S.; Elahi, E.; Mok, Z.Y.; Cheng, C.L.; Yan, B.; Pang, B.; Salto-Tellez, M. ; Yong, W.P. ; Iacopetta, B.; Soong, R.
28Mar-2013Effects of Hepatic Impairment on the Pharmacokinetics of Everolimus: A Single-Dose, Open-Label, Parallel-Group StudyPeveling-Oberhag, J.; Zeuzem, S.; Yong, W.P. ; Kunz, T.; Paquet, T.; Bouillaud, E.; Urva, S.; Anak, O.; Sellami, D.; Kobalava, Z.
913-Jun-2016Evolving landscape of tumor molecular profiling for personalized cancer therapy: a comprehensive reviewNicholas Li-Xun Syn; Wei-Peng Yong ; Boon-Cher Goh ; Soo-Chin Lee 
101-Jan-2023FAM3C in circulating tumor-derived extracellular vesicles promotes non-small cell lung cancer growth in secondary sitesThuya, WL ; Kong, LR ; Syn, NL; Ding, LW ; Cheow, ESH ; Wong, RTX ; Wang, T ; Goh, RMWJ; Song, H ; Jayasinghe, MK; Le, MTN; Hu, JC; Yong, WP ; Lee, SC ; Wong, ALA ; Sethi, G ; Hung, HT ; Ho, PCL ; Thiery, JP ; Sze, SK ; Guo, T; Soo, RA ; Yang, H; Lim, YC ; Wang, L ; Goh, BC 
112019FBXW5 Promotes Tumorigenesis and Metastasis in Gastric Cancer via Activation of the FAK-Src Signaling PathwayYeo; Subhash; KAZUTO SUDA ; HAYRI EMRAH BALCIOGLU ; ZHOU SIQIN ; THUYA WIN LWIN ; LOH XIN YI ; Jammula; PRAVEEN CHAKRAVARTHY PEETHALA ; Tan; Xie; Wong; Ladoux,Benoit ; Ito; YANG HE ; Goh; Wang; YONG WEI PENG 
123-May-2016Gelsolin-mediated activation of PI3K/Akt pathway is crucial for hepatocyte growth factor-induced cell scattering in gastric carcinomaHuang, Baohua ; DENG SHUO ; LOO SER YUE ; ARPITA DATTA ; YAP YAN LIN ; Yan, Benedict; OOI CHIA HUEY ; DINH THUY DUONG ; ZHUO JINGLI ; LALCHHANDAMI TOCHHAWNG ; SUMA GOPINADHAN ; Jegadeesan, Tamilarasi; TAN BOON OOI,PATRICK ; SALTO-TELLEZ,MANUEL ; YONG WEI PENG ; SOONG CHUAN TECK,RICHIE ; YEOH KHAY GUAN ; GOH YAW CHONG ; PETER EDWARD LOBIE ; YANG HE ; ALAN PREM KUMAR ; Maciver, Sutherland K; SO BOK YAN,JIMMY ; Yap Suen Mei,Celestial Therese 
13Sep-2011Gemcitabine and platinum pathway pharmacogenetics in Asian breast cancer patientsWong, A.L.-A.; Yap, H.-L.; Yeo, W.-L. ; Soong, R.; Ng, S.-S.; Wang, L.-Z.; Cordero, M.T.; Yong, W.-P. ; Goh, B.-C.; Lee, S.-C. 
14Aug-2011Germline genetic testing to predict drug response and toxicity in oncology- Reality or fiction?Soh, T.I.; Yong, W.P. 
152015GTSE1 expression represses apoptotic signaling and confers cisplatin resistance in gastric cancer cellsSubhash, V.V; Tan, S.H; Tan, W.L; Yeo, M.S; Xie, C; Wong, F.Y; Kiat, Z.Y; Lim, R; Yong, W.P 
161-Jul-2016High efficacy of BAY 1187982, an FGFR2-ADC, in overcoming drug resistance in a diffuse type gastric cancer patient-derived xenograft model with acquired resistance to pan-FGFR inhibitor AZD4547Lau, Wen Min ; Teng, Eileen ; Huang, Kie Kyon ; Tan, Jin Wei ; Teh, Ming ; Yong, Wei Peng ; Sommer, Anette; Schatz, Christoph A; Tan, Patrick ; Chan, Shing Leng ; So, Jimmy 
17Dec-2010Impact of sample heterogeneity on methylation analysisLoh, M. ; Liem, N.; Lim, P.L.; Vaithilingam, A.; Cheng, C.L.; Salto-Tellez, M. ; Yong, W.P. ; Soong, R. 
18Jan-2013Integrated epigenomics identifies BMP4 as a modulator of cisplatin sensitivity in gastric cancerIvanova, T.; Zouridis, H.; Wu, Y.; Cheng, L.L.; Tan, I.B.; Gopalakrishnan, V.; Ooi, C.H. ; Lee, J.; Qin, L.; Wu, J.; Lee, M.; Rha, S.Y.; Huang, D.; Liem, N.; Yeoh, K.G.; Yong, W.P. ; Teh, B.T.; Tan, P. 
19Aug-2011Intrinsic subtypes of gastric cancer, based on gene expression pattern, predict survival and respond differently to chemotherapyTan, I.B.; Ivanova, T.; Lim, K.H.; Ong, C.W. ; Deng, N. ; Lee, J.; Tan, S.H.; Wu, J.; Lee, M.H.; Ooi, C.H. ; Rha, S.Y.; Wong, W.K.; Boussioutas, A.; Yeoh, K.G.; So, J.; Yong, W.P. ; Tsuburaya, A.; Grabsch, H.; Toh, H.C.; Rozen, S. ; Cheong, J.H.; Noh, S.H.; Wan, W.K.; Ajani, J.A.; Lee, J.; Tellez, M.S. ; Tan, P. 
20Apr-2006Ketoconazole renders poor CYP3A phenotype status with midazolam as probe drugTham, L.-S.; Lee, H.-S.; Wang, L. ; Yong, W.-P. ; Fan, L.; Ong, A.-B.; Sukri, N.; Soo, R. ; Lee, S.-C. ; Goh, B.-C.